Genetically-informed prediction of short-term Parkinson’s disease progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2373-8057
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genetically-informed prediction of short-term Parkinson’s disease progression ; volume:8 ; number:1 ; day:28 ; month:10 ; year:2022 ; pages:1-11 ; date:12.2022
npj Parkinson's Disease ; 8, Heft 1 (28.10.2022), 1-11, 12.2022
- Urheber
-
Sadaei, Hossein J.
Cordova-Palomera, Aldo
Lee, Jonghun
Padmanabhan, Jaya
Chen, Shang-Fu
Wineinger, Nathan E.
Dias, Raquel
Prilutsky, Daria
Szalma, Sandor
Torkamani, Ali
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-022-00412-w
- URN
-
urn:nbn:de:101:1-2023011320593085696407
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sadaei, Hossein J.
- Cordova-Palomera, Aldo
- Lee, Jonghun
- Padmanabhan, Jaya
- Chen, Shang-Fu
- Wineinger, Nathan E.
- Dias, Raquel
- Prilutsky, Daria
- Szalma, Sandor
- Torkamani, Ali
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prevention of progression in Parkinson’s disease
Short-term temporal memory in idiopathic and Parkin-associated Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
Evaluating a motor progression connectivity model across Parkinson’s disease stages
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Simulating the progression of brain structural alterations in Parkinson’s disease
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson’s disease in animal models
Self-report data as a tool for subtype identification in genetically-defined Parkinson’s Disease
Disease progression strikingly differs in research and real-world Parkinson’s populations
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
Prevention of progression in Parkinson’s disease
Short-term temporal memory in idiopathic and Parkin-associated Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
Evaluating a motor progression connectivity model across Parkinson’s disease stages
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Simulating the progression of brain structural alterations in Parkinson’s disease
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson’s disease in animal models
Self-report data as a tool for subtype identification in genetically-defined Parkinson’s Disease
Disease progression strikingly differs in research and real-world Parkinson’s populations
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
Prevention of progression in Parkinson’s disease
Short-term temporal memory in idiopathic and Parkin-associated Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
Evaluating a motor progression connectivity model across Parkinson’s disease stages
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Simulating the progression of brain structural alterations in Parkinson’s disease
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson’s disease in animal models
Self-report data as a tool for subtype identification in genetically-defined Parkinson’s Disease
Disease progression strikingly differs in research and real-world Parkinson’s populations